ΨΥΧΗΣ ΙΑΤΡΕΙΟΝ

eCQMs for 2022 Performance Period

CMS2v11

Preventive Care & Screening: Screening for Depression & Follow-Up Plan

CMS22v10

Preventive Care & Screening: Screening for High Blood Pressure & Follow-Up Documented

CMS50v10

Closing the Referral Loop: Receipt of Specialist Report

CMS56v10

Functional Status Assessment for Total Hip Replacement

CMS66v10

Functional Status Assessment for Total Knee Replacement

CMS68v11

Documentation of Current Medications in the Medical Record

CMS69v10

Preventive Care & Screening: Body Mass Index (BMI) Screening & Follow-Up Plan

CMS74v11

Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists

CMS75v10

Children Who Have Dental Decay or Cavities

CMS90v11

Functional Status Assessments for Heart Failure

CMS117v10

Childhood Immunization Status

CMS122v10

Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)

CMS124v10

Cervical Cancer Screening

CMS125v10

Breast Cancer Screening

CMS127v10

Pneumococcal Vaccination Status for Older Adults

CMS128v10

Anti-depressant Medication Management

CMS129v11

Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

CMS130v10

Colorectal Cancer Screening

CMS131v10

Diabetes: Eye Exam

CMS133v10

Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery

CMS134v10

Diabetes: Medical Attention for Nephropathy

CMS135v10

Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor

CMS136v11

Follow-Up Care for Children Prescribed ADHD Medication (ADD)

CMS137v10

Initiation & Engagement of Alcohol & Other Drug Dependence Treatment

CMS138v10

Preventive Care & Screening: Tobacco Use: Screening & Cessation Intervention

CMS139v10

Falls: Screening for Future Fall Risk

CMS142v10

Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care

CMS143v10

Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation

CMS144v10

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS145v10

Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)

CMS146v10

Appropriate Testing for Pharyngitis

CMS147v11

Preventive Care & Screening: Influenza Immunization

CMS149v10

Dementia: Cognitive Assessment

CMS153v10

Chlamydia Screening for Women

CMS154v10

Appropriate Treatment for Upper Respiratory Infection (URI)

CMS155v10

Weight Assessment & Counseling for Nutrition & Physical Activity for Children/Adolescents

CMS156v10

Use of High-Risk Medications in Older Adults

CMS157v10

Oncology: Medical and Radiation - Pain Intensity Quantified

CMS159v10

Depression Remission at Twelve Months

CMS161v10

Adult Major Depressive Disorder (MDD): Suicide Risk Assessment

CMS165v10

Controlling High Blood Pressure

CMS177v10

Child & Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment

CMS249v4

Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture

CMS347v5

Statin Therapy for the Prevention & Treatment of Cardiovascular Disease

CMS349v4

HIV Screening

CMS645v5

Bone density evaluation for patients with prostate cancer & receiving androgen deprivation therapy

CMS646v2

Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer

CMS771v3

Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia

Copyright 2006-2023 Automated Clinical Guidelines, LLC.  All rights reserved.

Home  Contact  FAQ

Account